Cargando…

Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site

The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two m...

Descripción completa

Detalles Bibliográficos
Autores principales: Exell, Jack C., Thompson, Mark J., Finger, L. David, Shaw, Steven J., Debreczeni, Judit, Ward, Thomas A., McWhirter, Claire, Siöberg, Catrine L. B., Martinez Molina, Daniel, Mark Abbott, W., Jones, Clifford D., Nissink, J. Willem M., Durant, Stephen T., Grasby, Jane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348030/
https://www.ncbi.nlm.nih.gov/pubmed/27526030
http://dx.doi.org/10.1038/nchembio.2148
_version_ 1782514162005442560
author Exell, Jack C.
Thompson, Mark J.
Finger, L. David
Shaw, Steven J.
Debreczeni, Judit
Ward, Thomas A.
McWhirter, Claire
Siöberg, Catrine L. B.
Martinez Molina, Daniel
Mark Abbott, W.
Jones, Clifford D.
Nissink, J. Willem M.
Durant, Stephen T.
Grasby, Jane A.
author_facet Exell, Jack C.
Thompson, Mark J.
Finger, L. David
Shaw, Steven J.
Debreczeni, Judit
Ward, Thomas A.
McWhirter, Claire
Siöberg, Catrine L. B.
Martinez Molina, Daniel
Mark Abbott, W.
Jones, Clifford D.
Nissink, J. Willem M.
Durant, Stephen T.
Grasby, Jane A.
author_sort Exell, Jack C.
collection PubMed
description The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two magnesium ions. Three such compounds had similar IC(50) values but differed subtly in mode of action. One had comparable affinity for protein and protein–substrate complex and prevented reaction by binding to active site catalytic metal ions, blocking the unpairing of substrate DNA necessary for reaction. Other compounds were more competitive with substrate. Cellular thermal shift data showed engagement of both inhibitor types with hFEN1 in cells with activation of the DNA damage response evident upon treatment. However, cellular EC(50)s were significantly higher than in vitro inhibition constants and the implications of this for exploitation of hFEN1 as a drug target are discussed.
format Online
Article
Text
id pubmed-5348030
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-53480302017-03-23 Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site Exell, Jack C. Thompson, Mark J. Finger, L. David Shaw, Steven J. Debreczeni, Judit Ward, Thomas A. McWhirter, Claire Siöberg, Catrine L. B. Martinez Molina, Daniel Mark Abbott, W. Jones, Clifford D. Nissink, J. Willem M. Durant, Stephen T. Grasby, Jane A. Nat Chem Biol Article The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the first crystal structure of inhibitor-bound hFEN1 and show a cyclic N-hydroxyurea bound in the active site coordinated to two magnesium ions. Three such compounds had similar IC(50) values but differed subtly in mode of action. One had comparable affinity for protein and protein–substrate complex and prevented reaction by binding to active site catalytic metal ions, blocking the unpairing of substrate DNA necessary for reaction. Other compounds were more competitive with substrate. Cellular thermal shift data showed engagement of both inhibitor types with hFEN1 in cells with activation of the DNA damage response evident upon treatment. However, cellular EC(50)s were significantly higher than in vitro inhibition constants and the implications of this for exploitation of hFEN1 as a drug target are discussed. 2016-08-15 2016-10 /pmc/articles/PMC5348030/ /pubmed/27526030 http://dx.doi.org/10.1038/nchembio.2148 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Exell, Jack C.
Thompson, Mark J.
Finger, L. David
Shaw, Steven J.
Debreczeni, Judit
Ward, Thomas A.
McWhirter, Claire
Siöberg, Catrine L. B.
Martinez Molina, Daniel
Mark Abbott, W.
Jones, Clifford D.
Nissink, J. Willem M.
Durant, Stephen T.
Grasby, Jane A.
Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title_full Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title_fullStr Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title_full_unstemmed Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title_short Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site
title_sort cellular active n-hydroxyurea fen1 inhibitors block substrate entry to the active site
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348030/
https://www.ncbi.nlm.nih.gov/pubmed/27526030
http://dx.doi.org/10.1038/nchembio.2148
work_keys_str_mv AT exelljackc cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT thompsonmarkj cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT fingerldavid cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT shawstevenj cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT debreczenijudit cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT wardthomasa cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT mcwhirterclaire cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT siobergcatrinelb cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT martinezmolinadaniel cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT markabbottw cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT jonescliffordd cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT nissinkjwillemm cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT durantstephent cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite
AT grasbyjanea cellularactivenhydroxyureafen1inhibitorsblocksubstrateentrytotheactivesite